Catalyst Wire Dossier Catalyst Wire Dossier

IMVAMUNE (MVA-BN) Smallpox Vaccine

Modified vaccinia Ankara (MVA-BN) · Bavarian Nordic
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMVAMUNE (MVA-BN) Smallpox Vaccine, covering 2012-09-28 to 2012-09-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients [Phase 1, Phase 2]

See pricing